0.394
Outlook Therapeutics Inc (OTLK) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
1,248%
-1.2375
|
-0.0918 | 1.5053 | -0.0185 | 0.0489 |
| Cost Of Revenue |
96.77%
0.0296
|
0.9165 | 0.4398 | - | - |
| Gross Profit |
22.73%
-1.2375
|
-1.0083 | 1.0655 | - | - |
|
|
24.90%
12.25
|
16.31 | 16.81 | 12.37 | 21.66 |
| Benefits Costs and Expenses |
47.88%
21.82
|
14.76 | 21.66 | 46.34 | -17.33 |
| Costs And Expenses |
17.00%
12.25
|
14.76 | 21.66 | 46.34 | -17.33 |
| Depreciation and Amortization |
1.13%
0.0301
|
0.0297 | 0.0294 | - | - |
| Operating Income/Loss |
22.12%
-13.48
|
-17.31 | -15.75 | -12.39 | -21.61 |
| Net Interest Income/Expense |
100.00%
-
|
-0.2642 | -0.0494 | -0.0185 | 0.0489 |
| Income/Loss Before Equity Method Investments |
55.46%
-23.02
|
-14.81 | -20.12 | -46.32 | 17.41 |
| Income/Loss From Equity Method Investments |
4.42%
-0.0386
|
-0.0404 | -0.0309 | -0.0364 | -0.0333 |
| Income/Loss From Continuing Operations Before Tax |
55.30%
-23.06
|
-14.85 | -20.15 | -46.35 | 17.38 |
| Income/Loss From Continuing Operations After Tax |
73.46%
-23.06
|
-13.29 | -20.15 | -46.36 | 17.38 |
|
|
73.46%
-23.06
|
-13.29 | -20.15 | -46.36 | 17.38 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1,357%
60.21
|
4.1321 | 36.96 | 30.87 | -3.3567 |
| Diluted Average Shares |
1,357%
60.21
|
4.1321 | 36.96 | 30.87 | -3.3567 |
| Basic Earnings Per Share |
100.00%
-0.38
|
-0.19 | -0.55 | -1.50 | 0.45 |
| Diluted Earnings Per Share |
100.00%
-0.38
|
-0.19 | -0.55 | -1.50 | 0.45 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):